Idenix Pharmaceuticals Financial Market Data
| Last Close 14-Aug-2008 |
$8.77 |
Price/ Sales Ratio |
17.74 |
| 52-Week High |
$8.81 |
Price/ Book Ratio |
12.11 |
| 52-Week Low |
$2.10 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
(0.6) |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$494.6 |
Return on Assets |
(53.9%) |
| Shares Outstanding (mil.) |
56.4 |
Return on Equity |
(113.4%) |
| Dividend Rate |
-- |
Current Ratio |
3.09 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
74 |
% Owned by Institutions |
26.0% |
| Latest Short Interest Ratio |
12.15 |
Latest Net Insider Transactions |
400.00 |
| Revenue Growth |
(65.9%) |
(59.5%) |
0.0% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
